ArticlebioRxiv : the preprint server for biology2021
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory.
Sonia Ndeupen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.